Keshan disease and mitochondrial cardiomyopathy

Yang Fuyu1

  • 1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China. Yangfy@sun5.ibp.ac.cn

Insights

Keshan disease, a heart condition, is linked to mitochondrial damage and selenium deficiency. Research suggests classifying it as a type of mitochondrial cardiomyopathy, improving understanding of its causes and treatment.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pathology

Background:

  • Keshan disease (KD) is a fatal cardiomyopathy endemic to specific regions of China.
  • Previous research on mitochondrial cardiomyopathy was limited before the Chuxiong investigation.

Purpose of the Study:

  • To investigate the pathogenic mechanisms of Keshan disease.
  • To evaluate the classification of Keshan disease as a mitochondrial cardiomyopathy.

Main Methods:

  • A multidisciplinary investigation involving epidemiologists, clinicians, pathologists, biochemists, biophysicists, and environmental specialists.
  • Pathological, biochemical, and biophysical analyses of myocardial tissue from KD patients and controls.
  • Assessment of mitochondrial function, including oxidative phosphorylation and key molecular components.

Main Results:

  • Myocardium in KD patients showed enlarged mitochondria with distended cristae.
  • Significant reductions in oxidative phosphorylation enzyme activity, CoQ, cardiolipin, selenium, and GSHPx activity were observed.
  • Increased calcium ion (Ca2+) content and decreased selenium levels were noted in affected mitochondria.

Conclusions:

  • Mitochondria are identified as the primary target of pathogenic factors in Keshan disease.
  • Keshan disease is proposed to be classified as a form of mitochondrial cardiomyopathy.
  • Understanding KD's mechanism provides insights into general mitochondrial cardiomyopathy research.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...